Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Li Y

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5082-5914; OpenAlex author ID A5100334816, A5105286153. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2026: 3 papers

Papers 3

  1. Spatiotemporal heterogeneity of recurrence and predictors after radical surgery for pancreatic ductal adenocarcinoma: a retrospective observational study. Co-author DOI 10.1007/s00464-026-13120-w↗
  2. Removing therapy-induced senescent cancer cells targets and potentiates the response of pancreatic cancer cells toward PARP inhibitors as maintenance therapy. Co-author DOI 10.1007/s10495-025-02251-5↗
  3. Exosome-Coated Dendrimer Nanogels as a Therapeutic Vaccine for CT Imaging-Guided Chemoimmunotherapy of Pancreatic Cancer. Co-author DOI 10.1021/polymscitech.6c00065↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhuo Li · 1 shared paper, 2026 · strength 0.30
  2. Xiangyang Shi · 1 shared paper, 2026 · strength 0.30
  3. Zhaoshi Bai · 1 shared paper, 2026 · strength 0.29
  4. Tianrui Kuang · 1 shared paper, 2026 · strength 0.25
  5. Yunwei Sun · 1 shared paper, 2026 · strength 0.25
  6. Rui Wang · 1 shared paper, 2026 · strength 0.25
  7. Bing Peng · 1 shared paper, 2026 · strength 0.25
  8. Zhong Wu · 1 shared paper, 2026 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.